Navigation path

Lutter contre les maladies mortelles, projets du 6e PC financés par l'UE

Liste de projets du 6e PC classés par acronyme

(description des projets uniquement disponible en anglais)

ADVAC-EC Advanced Vaccinology Training for Scientists from ACC and Developing Countries: From Genomics to Vaccination Strategies for Communicable Diseases Linked to Poverty
AIDS-CoVAC Generation of a Coronavirus-Based Multigene AIDS Vaccine and Evaluation in a Preclinical SIV model
Allomicrovac A combined microbicidal-immunizing strategy against SIV and HIV infection
AntiMal Development of New Drugs for the Treatment of Malaria
Auto/AlloCell-HIV Development of a Novel Therapeutic HIV-1 Vaccine: Horizontal Gene Transfer by Using Apoptotic HIV-1 DNA Containing Activated T-cells
AVIP Aids Vaccine Integrated Project
BioMalPar Biology and Pathology of the Malaria Parasite
CASCADE Concerted Action on SeroConversion to AIDS and Death in Europe
CILMALVAC The Tetrahymena system as an innovative approach to malaria antigene expression
CPN-YAS-PRD Contact Point Network to Attract Young African Scientists to Participate in EU-Funded PRD Research Projects
CSI LTB The role of chromosome stability in persistence, latency and reactivation of Mycobacterium tuberculosis
DEC-VAC Development of a Dendritic Cell-targeted Vaccine against AIDS
DETECTHIV Sensitive Nanoparticle Assay For the Detection of HIV
EAGLES European Action in Global Life Sciences - Health Programme
EMPRO European Microbicides project
EMVDA The European Malaria Vaccine Development Association
EPIVAC Development of a multi-step Improved Epidermis Specific Vaccine Candidate against HIV/AIDS
EPI-VAC Identification of Novel Epitopes as HIV-1 Vaccine Candidates
EURHAVAC European Network for Harmonisation of MalariaVaccine Development
EuropeHIVResistance European Cohort Coordinating Network on HIV Drug Resistance
EUROPRISE European Vaccines and Microbicides Enterprise
EuroSIDA 2005-2009 The EuroSIDA Network 2005-2009 – Clinical and Virological Outcome of Patients with HIV under Care in Europe
ExCellENT-HIT Exploiting Cellular Transport of Nuclear Transcripts as HIV Innovative Therapy
FASTEST-TB Development and Clinical Evaluation of Fast Tests for Tuberculosis Diagnosis
GISHEAL Genetic and Immunological Studies of European and African HIV-1+ Long Term Non-Progressors
HIDDEN HIV CHALLENGE Challenging the Hidden HIV: Understanding the Block on Transcriptional Reactivation to Eradicate Infection
HIV PI resistance HIV protease inhibitor resistance by enzyme- substrate coevolution
HIV VIROSOMES Development of a New Vaccine Against HIV: Virosomes Incorporating HIV proteins
HIVResInh Preparation and Identification of New HIV Reverse Transcriptase Inhibitors Targeted Against HIV Strains Resistant to anti-HIV/AIDS drugs
HIVAB Generation of Broadly Cross Neutralising Antibodies for Innovative Active-passive HIV Vaccination Strategies Based on Modified Ig-gene Transgenic Mice
HIVSTOP Development of an Effective RNA Interference-Based Anti-HIV-1 Therapy Using an SV40-Derived Vector
HUMALMAB Human monoclonal antibodies as tools for malaria research and therapy
Immuno VacTB A new approach for developing a less Immunosuppressive Vaccine for Tuberculosis
INNOVAC Highly Innovative Strategies for Vaccination to Poverty Related Diseases
Malaria Age Exposure Age of Exposure and Immunity to Malaria in Infants
MalariaPorin Validation of the Plasmodium Aquaglyceroporin as a Drug Target
MALINV Differential Expression of Malaria Invasion-Associated Proteins in the porozoite: Novel Vaccination Strategy
MILD-TB Immunogenicity of Mycobacterium Tuberculosis lipids in the Non Replicating Status of latency
MM-TB Molecular Markers of M. tuberculosis Early Interactions with Host Phagocytes
MPCM Pathogenic Role of MicroParticles in Cerebral Malaria
MUNANO VAC Mucosal Nano Vaccine Candidate for HIV
MUVAPRED Mucosal Vaccines for Poverty Related Diseases
MVACTOR Host Immune Activation Optimised Vaccinia Virus Vectors for Vaccine Development
MYCOMANCY Transcriptional Regulation And Cellular Localisation Of Mycobacterial Cell Cycle Proteins During Dormancy
NEAT The European AIDS Treatment Network
Neotim Innate and adaptive immunity in clinical and experimental mycobacterial infection in neonates and infants
NeutNet Standardisation of HIV Neutralisation Assays to be Used in Vaccine Research and Clinical Trials
NEWHIVTARGETS Identifying novel classes of HIV inhibitors
NEWTBDRUGS New Drugs for Persistent Tuberculosis: Exploitation of 3-D Structure of Novel Targets, Lead Optimisation and Functional In-Vivo Evaluation
NM4TB New Medicines for Tuberculosis
PENTA/ECS Paediatric European Network for Treatment of AIDS and European Collaborative Study on HIV-infected pregnant women and their children
PHARMA-PLANTA Recombinant Pharmaceuticals from Plants for Human Health
Pox-gene A Combined Pox-virus/Lentiviral Vector System to Treat HIV Infection; Immunisation and Direct In Vivo Gene Transfer in T-Lymphocytes
PRIBOMAL Preclinical Studies towards an Affordable, Safe and Efficacious Two-Component Paediatric Malaria Vaccine
Plasmodium dUTPase Deoxyuridine Triphosphate Nucleotidohydrolase as a Drug Target against Malaria
READ-UP Redox Antimalarial Drug discovery
RMVHIV Recombinant Measles Virus as a Vector for HIV Vaccines
scrIN-SILICO Finding Promising Drug Candidates Against Tuberculosis with
Multidisciplinary Protocol Based Non-Conventional Search
SENSITIVE TARGETS Oxygen-Sensitive Enzymes of the Mevalonate-Independent Isoprenoid Biosynthesis Pathway as Targets for New Antimalarial and Anti-TB Drugs
SERO-TB Development of a Specific Serological Kit for the Diagnosis of TB
SHIVA Selection and Development of Microbicides for Mucosal Use to Prevent Sexual HIV Transmission/Acquisition
SIGMAL Targeting Malaria Transmission Through Interference with Signalling in Plasmodium falciparum Gametocytogenesis
SME Malaria SME Led Malaria Vaccine Initiative
TB Treatment Marker Establishing a TB Treatment Efficacy Marker
TBMACS Identification and characterisation of Mycobacterium tuberculosis virulence genes involved in macrophage parasitism
TBADAPT Effect of Genetic Variation in Mycobacterium Tuberculosis on Vaccine Escape and the Acquisition of Drug Resistance
TB-DRUG OLIGOCOLOR Development of a Molecular Platform for the Simultaneous Detection of Mycobacterium tuberculosis Resistance to Rifampicin and Fluoroquinolones
TBIRIS Pathogenesis and identification of predictive factors of TB-IRIS in HIV patients under HAART
TB-trDNA Evaluation of Transrenal-DNA Detection to Diagnose Tuberculosis
TB-VAC TB-VAC: An Integrated Project for New Vaccines against Tuberculosis
Teach CD4 International CD4 T-Lymphocyte Training Programme for the Support of HIV Clinical Trials Networks
TIP-VAC Explaining and Improving Efficacy of Targeted Immunodeficiency Virus-like Particle Vaccines against AIDS
TRIoH Targeting Replication and Integration of HIV
Tuberculosis China The Diversity of Mycobacterium Tuberculosis Strains in China: Tracing the Origins of the Worldwide Dispersion of the Multidrug-Resistant Beijing Genotype
UNITE-MORE Uniformity in Testing and Monitoring HIV Resistance
Vaccines4TB Genome- and HLA- Wide Scanning and Validation of Cytotoxic CD8 T Cell Responses against Mycobacterium Tuberculosis
VaccTIP Vaccine Strategies for Combined Targeting of Innate and Adaptive Immune Pathways
VIAV Very Innovative AIDS Vaccine
VirApt Antiviral Aptamers for Treatment of HIV-1 Infection
VITBIOMAL Vitamin Biosynthesis as a Target for Antimalarial Therapy